Capecitabine Plus Cisplatin Treatment for Advanced Gastric Cancer in a Patient With Hepatic Impairment Secondary to Metastases

Lignende værker

• Targeting MET Amplification as a New Oncogenic Driver
  af: Kawakami, Hisato, et al.
  Udgivet: (2014)
• Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors
  af: Fujisaka, Yasuhito, et al.
  Udgivet: (2014)
• Risk Factors for Cisplatin-Induced Nephrotoxicity and Potential of Magnesium Supplementation for Renal Protection
  af: Kidera, Yasuhiro, et al.
  Udgivet: (2014)
• Phase I/II Study of Cisplatin plus Nab‐Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non‐Small Cell Lung Cancer
  af: Hayashi, Hidetoshi, et al.
  Udgivet: (2020)
• Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma
  af: Sun, Xue-Song, et al.
  Udgivet: (2020)